{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:58:34Z","timestamp":1792587514106,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,16]]},"DOI":"10.7759\/cureus.29219","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T08:47:36Z","timestamp":1663318056000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical Profile of Patients Admitted With Mucormycosis During the COVID-19 Pandemic in Medicine Emergency of a Tertiary Care Hospital in North India"],"prefix":"10.7759","author":[{"given":"Neeraj","family":"Singla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandip","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta S","year":"2020","unstructured":"Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020, 12:e10726. 10.7759\/cureus.10726","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00472-7","article-title":"Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran","volume":"185","author":"Salehi M","year":"2020","unstructured":"Salehi M, Ahmadikia K, Badali H, Khodavaisy S. Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran. Mycopathologia. 2020, 185:607-11. 10.1007\/s11046-020-00472-7","journal-title":"Mycopathologia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"Chowdhary A","year":"2020","unstructured":"Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emerg Infect Dis. 2020, 26:2694-6. 10.3201\/eid2611.203504","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy060.","article-title":"A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","author":"Prakash H","year":"2018","unstructured":"Prakash H, Ghosh A, Rudramurthy S, et al.. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med. Mycol. 2018, 10.1093\/mmy\/myy060.","journal-title":"Med. Mycol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-0991-6","article-title":"Pulmonary mucormycosis: clinical features and outcomes","volume":"45","author":"Lin E","year":"2017","unstructured":"Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection. 2017, 45:443-8. 10.1007\/s15010-017-0991-6","journal-title":"Infection"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar S","year":"2021","unstructured":"Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021, 69:1002-4. 10.4103\/ijo.IJO_3763_20","journal-title":"Indian J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev K","year":"2021","unstructured":"Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and COVID-19 pneumonia. J Med Cases. 2021, 12:85-9. 10.14740\/jmc3637","journal-title":"J Med Cases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jof4020046","article-title":"Mucormycosis: battle with the deadly enemy over a five-year period in India","volume":"4","author":"Chander J","year":"2018","unstructured":"Chander J, Kaur M, Singla N, et al.. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi (Basel). 2018, 4:10.3390\/jof4020046","journal-title":"J Fungi (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: We should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/iai.46.2.346-353.1984","article-title":"Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis","volume":"46","author":"Restrepo A","year":"1984","unstructured":"Restrepo A, Salazar ME, Cano LE, Stover EP, Feldman D, Stevens DA. Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun. 1984, 46:346-53. 10.1128\/iai.46.2.346-353.1984","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312688","article-title":"Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis","volume":"103","author":"Kashkouli MB","year":"2019","unstructured":"Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2019, 103:1460-5. 10.1136\/bjophthalmol-2018-312688","journal-title":"Br J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel A","year":"2020","unstructured":"Patel A, Kaur H, Xess I, et al.. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020, 26:944.e9-944.e15. 10.1016\/j.cmi.2019.11.021","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-019-01774-z","article-title":"Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy","volume":"72","author":"Gupta S","year":"2020","unstructured":"Gupta S, Goyal R, Kaore NM. Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy. Indian J Otolaryngol Head Neck Surg. 2020, 72:104-11. 10.1007\/s12070-019-01774-z","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash H","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, et al.. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019, 57:395-402. 10.1093\/mmy\/myy060","journal-title":"Med Mycol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin DA","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020, 383:2451-60. 10.1056\/NEJMcp2009575","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes JA","year":"2000","unstructured":"Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000, 13:236-301. 10.1128\/CMR.13.2.236","journal-title":"Clin Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos G","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008, 47:503-9. 10.1086\/590004","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid G","year":"2020","unstructured":"Reid G, Lynch JP 3rd, Fishbein MC, Clark NM. Mucormycosis. Semin Respir Crit Care Med. 2020, 41:99-114. 10.1055\/s-0039-3401992","journal-title":"Semin Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13175","article-title":"A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years?","volume":"43","author":"Vaughan C","year":"2018","unstructured":"Vaughan C, Bartolo A, Vallabh N, Leong SC. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years?. Clin Otolaryngol. 2018, 43:1454-64. 10.1111\/coa.13175","journal-title":"Clin Otolaryngol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54 Suppl 1","author":"Petrikkos G","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54 Suppl 1:S23-34. 10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11776","article-title":"Rhinocerebral Mucormycosis: A Ten-Year Single Centre Case Series","volume":"12","author":"Balai E","year":"2020","unstructured":"Balai E, Mummadi S, Jolly K, Darr A, Aldeerawi H. Rhinocerebral Mucormycosis: A Ten-Year Single Centre Case Series. Cureus. 2020, 12:e11776. 10.7759\/cureus.11776","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.20329","article-title":"Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department","volume":"317","author":"Freund Y","year":"2017","unstructured":"Freund Y, Lemachatti N, Krastinova E, et al.. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 2017, 317:301-8. 10.1001\/jama.2016.20329","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245025","article-title":"A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients","volume":"16","author":"Valerio Pascua F","year":"2021","unstructured":"Valerio Pascua F, Diaz O, Medina R, et al.. A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients. PLoS One. 2021, 16:e0245025. 10.1371\/journal.pone.0245025","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","volume":"9","author":"Raut A","year":"2021","unstructured":"Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?. Lancet Respir Med. 2021, 9:e77. 10.1016\/S2213-2600(21)00265-4","journal-title":"Lancet Respir Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.01.002","article-title":"Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports","volume":"53","author":"Jeong W","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, Kong DC. Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports. Int J Antimicrob Agents. 2019, 53:589-97. 10.1016\/j.ijantimicag.2019.01.002","journal-title":"Int J Antimicrob Agents"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113337-clinical-profile-of-patients-admitted-with-mucormycosis-during-the-covid-19-pandemic-in-medicine-emergency-of-a-tertiary-care-hospital-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:20Z","timestamp":1707507560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113337-clinical-profile-of-patients-admitted-with-mucormycosis-during-the-covid-19-pandemic-in-medicine-emergency-of-a-tertiary-care-hospital-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.29219","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}